INVESTOR RELATIONS

Investor relations

NEWS

Lipum has identified the novel target molecule Bile Salt-Stimulated Lipase (BSSL). Preclinical studies have very successfully verified the concept in several...

INVESTOR RELATIONS

Investor relations